Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (Q24202939)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery	scientific article

Statements

scholarly article

0 references

0 references

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

0 references

Cheng-Fang Hsieh

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Mansur A Kutlubaev

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Graeme J. Hankey

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

author name string

Gillian E Mead

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Rebecca Lee

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Anne Claxton

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

publication date

14 November 2012

0 references

Cochrane Database of Systematic Reviews

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

CD009286

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine as a treatment for post-stroke emotionalism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Sertraline in stroke-associated lability of mood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

[Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness].

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Mortality and poststroke depression: a placebo-controlled trial of antidepressants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Escitalopram and enhancement of cognitive recovery following stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine improves the quality of life in patients with poststroke emotional disturbances

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Depressive disorders in neurologic rehabilitation: therapy with paroxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Clinical Studies on Event-Related Potentials (ERPS) N400 and the Related Factors in Patients with Poststroke Depression (PSD)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Sertraline in the treatment of post-stroke depression--results of an open multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Citalopram improves dexterity in chronic stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Antidepressants in the treatment of stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Antidepressant prophylaxis for poststroke depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Interventions for treating depression after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Interventions for preventing depression after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Pharmaceutical interventions for emotionalism after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Rate, degree, and predictors of recovery from disability following ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Time frame and predictors of recovery from disability following recurrent ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Adult neurogenesis in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Selective serotonin-reuptake inhibitors and recovery after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine and sertraline attenuate postischemic brain injury in mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Preventing stroke: saving lives around the world

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Pharmacologic treatment of poststroke depression: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Repairing brain after stroke: a review on post-ischemic neurogenesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Preventing Depression After Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Sertraline in stroke-associated lability of mood

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience from a multicentre stroke register: a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in early poststroke depression: a double-blind placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-stroke depression: an experience in using cipramil

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-ischemia neurologic recovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coaxil efficacy in depression in patients with chronic cerebral ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The brain-resuscitation acupuncture method for treatment of post wind-stroke mental depression--a report of 45 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult neurogenesis and neuroplasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventing depression after stroke: Results from a randomized placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Observation on effect of Wuling Capsule in treating poststroke depression]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose of fluoxetine increases muscle activation in chronic stroke patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Linggui Bafa on the therapeutic effect and quality of life in patients of post-stroke depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical observation on acupuncture treatment of 150 cases of post-stroke depression according to syndrome differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective treatment of depression following apoplexy with citalopram

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Therapy of post-stroke depression with fluoxetine. A pilot project]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of early treatment of poststroke depression on neuropsychological rehabilitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23152272

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of the Cerebral Microvascular Blood Flow with Brain Temperature and Electro-Acupuncture Stimulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term administration of fluoxetine to improve motor recovery after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD009286.PUB2

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24202939&oldid=1973193777"